CVE-2023-49134

Description

A command execution vulnerability exists in the tddpd enable_test_mode functionality of Tp-Link AC1350 Wireless MU-MIMO Gigabit Access Point (EAP225 V3) v5.1.0 Build 20220926 and Tp-Link N300 Wireless Access Point (EAP115 V4) v5.0.4 Build 20220216. A specially crafted series of network requests can lead to arbitrary command execution. An attacker can send a sequence of unauthenticated packets to trigger this vulnerability.This vulnerability impacts `uclited` on the EAP115(V4) 5.0.4 Build 20220216 of the N300 Wireless Gigabit Access Point.

Category

8.1
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.14%
Affected: Tp-Link AC1350 Wireless MU-MIMO Gigabit Access Point (EAP225 V3)
Affected: Tp-Link N300 Wireless Access Point (EAP115)
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-49134?
CVE-2023-49134 has been scored as a high severity vulnerability.
How to fix CVE-2023-49134?
To fix CVE-2023-49134, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-49134 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-49134 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-49134?
CVE-2023-49134 affects Tp-Link AC1350 Wireless MU-MIMO Gigabit Access Point (EAP225 V3), Tp-Link N300 Wireless Access Point (EAP115).
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.